Analyzing Mendel Money Management's Q3 2022 Portfolio Holdings Ahead of Q4 2022 13F Release

As investors in the Mendel Money Management fund await the release of the Q4 2022 13F holdings, it is worth looking back at the Q3 2022 holdings to see how they changed during that period. Mendel Money Management's holdings report showed that the fund had a total market value of $107.5 billion in Q3 2022, spread out among 57 stocks. The top holdings included Thermo Fisher Scientific, Microsoft Corporation, and Danaher Corp.

In terms of changes in holdings during the quarter, there were some interesting movements. Thermo Fisher Scientific, for example, saw an increase in shares from 12,818 to 12,877, with a corresponding increase in value from $6,501,000 to $7,091,000, representing a 9.1% change. Similarly, Microsoft Corp saw a 8.8% increase in shares held, from 27,695 to 29,275, with a corresponding increase in the value of the shares from $6,450,000 to $7,020,000.

While some stocks saw sizable increases in value, others saw decreases. For example, CSCO - Cisco Systems Inc - saw the number of shares held go up from 10,033 in Q3 2022 to a staggering 159,812 shares in Q4 2022. This represents a 1,494% increase in shares held, while the corresponding value of the shares went up only marginally, from $401,000 to $761,000 - a 89.9% increase. Conversely, Amazon.com Inc. saw a decrease in shares held from 40,781 to 40,403, with a corresponding decrease in value from $4,608,000 to $3,393,000, which translates to a 26.3% reduction.

Another significant change in holdings seen during the quarter was the increase in holdings of Deere & Co - a large agricultural machinery and equipment manufacturer. The number of shares held by the fund went up from 8,887 to 10,365, with a corresponding increase in the value of the shares from $2,967,000 to $4,444,000 - a 49.8% increase. This could be due to the increasing demand for food and agricultural products due to the global population growth.

Some existing holdings did not see much change in their value, such as Abbott Laboratories, which saw almost no change in the number of shares held - 9,912 in Q3 2022 compared to 9,872 in Q4 2022 - and only a 13% increase in the value of the shares, from $959,000 to $1,083,000.

Overall, while there were some notable changes in Mendel Money Management's holdings during the quarter, most of the changes were relatively small in percentage terms. Some stocks performed better than others, but the fund largely maintained its positions in its top holdings. It remains to be seen what the Q4 2022 13F holdings will reveal and whether there will be any significant shifts in the fund's strategy.